ERLOTINIB

Erlotinib · Camber Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

255 regulatory and trial events tracked for ERLOTINIB, covering 2007-12-21 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial) [Phase 3]

See pricing